Big Five Personality Factors in Benzodiazepine abuse: Brief Intervention controlled study
- Conditions
- Health Condition 1: F139- Sedative, hypnotic or anxiolytic-related use, unspecified
- Registration Number
- CTRI/2023/10/058797
- Lead Sponsor
- Central Institute of Psychiatry
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
a. Patients who are abusing benzodiazepine (Bendep-SRQ score is equal to 2 or above) with comorbid substance use disorder as per ICD-10, Classification of Mental and Behavioural Disorders, DCR, WHO, 1993.
b. Age range 18 to 60 years
c. Male gender
d. Minimum level of education is 5th grade, who can read and write.
e. Patients who give informed consent for the study.
a. Patients who have a history of significant medical or neurological and chronic physical illness.
b. Patients who are currently in withdrawal and delirium.
c. Patients who have any other mental illness apart from mild to moderate anxiety (score of less than 24 on HAM-A) and mild to moderate depression ( score of less than 18 on HAM-D)
d. Patients unwilling to participate for the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess motivation for change, locus of control and craving in patients with benzodiazepine abuse with comorbid substance use disorder.Timepoint: Before and after the intervention <br/ ><br>After 1 month
- Secondary Outcome Measures
Name Time Method To assess anxiety and depression and the effect of single session MET on anxiety and depression among patients with benzodiazepine abuse with comorbid substance use disorders.Timepoint: Before and after the intervention <br/ ><br>After 1 month